Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acute monophasic erythromelalgia pain in five children diagnosed as small-fiber neuropathy. | Eur J Paediatr Neurol | 2020 | 32723684 | PubTator, text mining | PubMed |
| Development and implementation of the SUM breast cancer cell line functional genomics knowledge base. | NPJ Breast Cancer | 2020 | 32715085 | PubTator, text mining | PubMed |
| FGF2-induced PI3K/Akt signaling evokes greater proliferation and adipogenic differentiation of human adipose stem cells from breast than from abdomen or thigh. | Aging (Albany NY) | 2020 | 32706337 | PubTator, text mining | PubMed |
| Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients. | Front Oncol | 2020 | 32695676 | PubTator, text mining | PubMed |
| Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism. | Nat Metab | 2020 | 32694731 | PubTator, text mining | PubMed |
| Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma. | Clin Transl Gastroenterol | 2020 | 32677805 | PubTator, text mining | PubMed |
| The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility. | Transl Lung Cancer Res | 2020 | 32676327 | PubTator, text mining | PubMed |
| Genetics and signaling mechanisms of orofacial clefts. | Birth Defects Res | 2020 | 32666711 | PubTator, text mining | PubMed |
| Unexpected favorable outcome to sintilimab plus bevacizumab in an EGFR-mutated non-small cell lung cancer patient: A case report. | Thorac Cancer | 2020 | 32656988 | PubTator, text mining | PubMed |
| Effects of Low-Dose Antibiotics on Gut Immunity and Antibiotic Resistomes in Weaned Piglets. | Front Immunol | 2020 | 32655541 | PubTator, text mining | PubMed |
| Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms. | J Clin Med | 2020 | 32650390 | PubTator, text mining | PubMed |
| Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer. | Cancers (Basel) | 2020 | 32650388 | PubTator, text mining | PubMed |
| Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy. | Breast Cancer Res Treat | 2020 | 32638235 | PubTator, text mining | PubMed |
| Molecular Cytogenomic Characterization of the Murine Breast Cancer Cell Lines C-127I, EMT6/P and TA3 Hauschka. | Int J Mol Sci | 2020 | 32630352 | PubTator, text mining | PubMed |
| Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma. | PeerJ | 2020 | 32617189 | PubTator, text mining | PubMed |
| MicroRNA's - The vibrant performers in the oral cancer scenario. | Jpn Dent Sci Rev | 2020 | 32612717 | PubTator, text mining | PubMed |
| Expression Atlas of FGF and FGFR Genes in Pancancer Uncovered Predictive Biomarkers for Clinical Trials of Selective FGFR Inhibitors. | Biomed Res Int | 2020 | 32596330 | PubTator, text mining | PubMed |
| Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication. | J Immunother Cancer | 2020 | 32581041 | PubTator, text mining | PubMed |
| New generation breast cancer cell lines developed from patient-derived xenografts. | Breast Cancer Res | 2020 | 32576280 | PubTator, text mining | PubMed |
| Stromal LAG-3+ cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture. | J Immunother Cancer | 2020 | 32540859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=42